2026 · 3rd Quarter (July 1 - Sep 30)
Filed by ARTEMIS POLICY GROUP LLC.
Open official filingSource-reported fields
Literal source text
Potential legislation on hospital emergency department care of people with sickle cell disease Education and support for Congressional Sickle Cell Disease Caucus Sickle Cell Disease Treatment Centers Act, S. 5488/HR 10531 Sickle Cell Care Expansion Act, S. 5489 Meeting with Department of HHS, Office of Minority Health
Literal federal measure citations: S. 5488, HR 10531, S. 5489
Engagement with the Center for Medicare and Medicaid Innovation on the Cell & Gene Therapy Access Model Sickle Cell Disease Comprehensive Care Act (S. 721/H.R. 5178) Medicaid eligibility and coverage for needed services for people living with sickle cell disease Implementation of Medicaid Community Engagement provisions of HR 1
Funding for federal sickle cell disease programs Funding and staffing for the CDC Division of Blood Disorders and Public Health Genomics Letter to CDC Director Erica Schwartz re Division of Blood Disorders & Public Health Genomics Funding for and continuation of HRSAs Sickle Cell Disease Newborn Screening Follow Up Program Letter to Secretary Kennedy re HRSA SCD Newborn Screening Follow Up Program FY27 House and Senate Labor-HHS Appropriations
Implementation of H.R. 1, One Big Beautiful Bill Act Comment letter in response to CMS IFR re Medicaid Program: Community Engagement Requirement for Certain Individuals Policies related to Medicaid and ACA Marketplace plans
Literal federal measure citations: H.R. 1
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
